| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 10-Q | Report | Data | 10-Q | Nov 6, 2024 | Sep 30, 2024 |
| 8-K | Report | Data | 8-K | Nov 6, 2024 | Nov 6, 2024 |
| SC 13G/A | Report | SC 13G/A | Nov 6, 2024 | |
| SC 13G/A | Report | Oct 23, 2024 | ||
| 8-K | Report | Data | 8-K | Oct 21, 2024 | Oct 21, 2024 |
| 8-K | Report | Data | 8-K | Oct 4, 2024 | Oct 3, 2024 |
| 8-K | Report | Data | 8-K | Oct 1, 2024 | Sep 27, 2024 |
| 10-Q | Report | Data | 10-Q | Aug 8, 2024 | Jun 30, 2024 |
| 8-K | Report | Data | 8-K | Aug 8, 2024 | Aug 8, 2024 |
| SC 13G/A | Report | Jul 11, 2024 | ||
| 8-K | Report | Data | 8-K | Jun 13, 2024 | Jun 13, 2024 |
| SC 13D/A | Report | NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS, INC. -- SCHEDULE 13D/A( | May 21, 2024 | |
| 10-Q | Report | Data | 10-Q | May 7, 2024 | Mar 31, 2024 |
| 8-K | Report | Data | 8-K | May 7, 2024 | May 7, 2024 |
| SC 13G/A | Report | TRVI_13GA01 | Apr 25, 2024 | |
| 10-K | Report | Data | 10-K | Mar 20, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | 8-K | Mar 20, 2024 | Mar 20, 2024 |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G/A | Report | Feb 14, 2024 | ||
| SC 13G/A | Report | SC 13G/A | Feb 12, 2024 | |
| 10-Q | Report | Data | 10-Q | Nov 9, 2023 | Sep 30, 2023 |
| 8-K | Report | Data | 8-K | Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Report | Data | 10-Q | Aug 10, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | 8-K | Aug 10, 2023 | Aug 10, 2023 |
| 8-K | Report | Data | 8-K | Jun 29, 2023 | Jun 28, 2023 |
| 10-Q | Report | Data | 10-Q | May 11, 2023 | Mar 31, 2023 |
| 8-K | Report | Data | 8-K | May 11, 2023 | May 11, 2023 |
| 8-K | Report | Data | 8-K | Apr 14, 2023 | Apr 13, 2023 |
| 10-K | Report | Data | 10-K | Mar 16, 2023 | Dec 31, 2022 |
| 8-K | Report | Data | 8-K | Mar 16, 2023 | Mar 16, 2023 |
| SC 13G | Report | TREVI SC 13GA | Feb 15, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G/A | Report | AMENDMENT TO FORM SC 13G | Feb 10, 2023 | |
| SC 13G | Report | SC 13G | Feb 10, 2023 | |
| 10-Q | Report | Data | 10-Q | Nov 10, 2022 | Sep 30, 2022 |
| 8-K | Report | Data | 8-K | Nov 10, 2022 | Nov 10, 2022 |
| SC 13G | Report | SC 13G | Oct 7, 2022 | |
| SC 13G/A | Report | SC 13G/A | Oct 7, 2022 | |
| 8-K | Report | Data | 8-K | Sep 23, 2022 | Sep 22, 2022 |
| 8-K | Report | Data | 8-K | Sep 19, 2022 | Sep 19, 2022 |
| 10-Q | Report | Data | 10-Q | Aug 11, 2022 | Jun 30, 2022 |
| 8-K | Report | Data | 8-K | Aug 11, 2022 | Aug 11, 2022 |
| 8-K | Report | Data | 8-K | Jun 29, 2022 | Jun 29, 2022 |
| 8-K | Report | Data | 8-K | Jun 23, 2022 | Jun 23, 2022 |
| 8-K | Report | Data | 8-K | May 16, 2022 | May 13, 2022 |
| 10-Q | Report | Data | 10-Q | May 12, 2022 | Mar 31, 2022 |
| 8-K | Report | Data | 8-K | May 12, 2022 | May 12, 2022 |
| SC 13D/A | Report | NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A3 | Apr 25, 2022 | |
| SC 13G | Report | SC 13G | Apr 21, 2022 | |
| SC 13G | Report | SC 13G | Apr 21, 2022 | |
| SC 13G | Report | SC 13G | Apr 18, 2022 | |
| SC 13G | Report | MAI 13G | Apr 8, 2022 | |
| 8-K | Report | Data | 8-K | Apr 7, 2022 | Apr 6, 2022 |
| 10-K | Report | Data | 10-K | Mar 17, 2022 | Dec 31, 2021 |
| 8-K | Report | Data | 8-K | Mar 17, 2022 | Mar 17, 2022 |
| 8-K | Report | Data | 8-K | Mar 16, 2022 | Mar 16, 2022 |
| SC 13G | Report | SC 13G | Mar 9, 2022 | |
| SC 13G | Report | SC 13G | Mar 9, 2022 | |
| 8-K | Report | Data | 8-K | Feb 24, 2022 | Feb 24, 2022 |
| SC 13G | Report | SC 13G | Feb 14, 2022 | |
| SC 13G/A | Report | AMENDMENT TO FORM SC 13G | Feb 11, 2022 | |
| 8-K | Report | Data | 8-K | Feb 1, 2022 | Feb 1, 2022 |
| SC 13G/A | Report | SC 13G/A | Jan 26, 2022 | |
| 8-K | Report | Data | 8-K | Jan 14, 2022 | Jan 10, 2022 |
| 8-K | Report | Data | 8-K | Jan 5, 2022 | Jan 5, 2022 |
| 10-Q | Report | Data | 10-Q | Nov 10, 2021 | Sep 30, 2021 |
| 8-K | Report | Data | 8-K | Nov 10, 2021 | Nov 10, 2021 |
| SC 13D/A | Report | NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A2 | Nov 2, 2021 | |
| 8-K | Report | Data | 8-K | Oct 19, 2021 | Oct 15, 2021 |
| 8-K | Report | Data | 8-K | Oct 1, 2021 | Sep 30, 2021 |
| 10-Q | Report | Data | 10-Q | Aug 12, 2021 | Jun 30, 2021 |
| 8-K | Report | Data | 8-K | Aug 12, 2021 | Aug 12, 2021 |
| 8-K | Report | Data | 8-K | Aug 9, 2021 | Aug 9, 2021 |
| 8-K | Report | Data | 8-K | Jul 9, 2021 | Jul 9, 2021 |
| 8-K | Report | Data | 8-K | Jul 7, 2021 | Jul 6, 2021 |
| 8-K | Report | Data | 8-K | Jun 21, 2021 | Jun 16, 2021 |
| 8-K | Report | 8-K | Jun 21, 2021 | Jun 18, 2021 |
| 10-Q | Report | Data | 10-Q | May 13, 2021 | Mar 31, 2021 |
| 8-K | Report | 8-K | May 13, 2021 | May 13, 2021 |
| 8-K | Report | 8-K | Apr 2, 2021 | Mar 29, 2021 |
| 10-K | Report | Data | 10-K | Mar 25, 2021 | Dec 31, 2020 |
| 8-K | Report | 8-K | Mar 25, 2021 | Mar 25, 2021 |
| 8-K | Report | 8-K | Mar 22, 2021 | Mar 18, 2021 |
| SC 13G/A | Report | AMENDMENT TO FORM SC 13G | Feb 12, 2021 | |
| 10-Q | Report | Data | 10-Q | Nov 12, 2020 | Sep 30, 2020 |
| 8-K | Report | 8-K | Nov 12, 2020 | Nov 11, 2020 |
| 8-K | Report | 8-K | Oct 21, 2020 | Oct 21, 2020 |
| 8-K | Report | 8-K | Sep 11, 2020 | Sep 8, 2020 |
| 10-Q | Report | Data | 10-Q | Aug 13, 2020 | Jun 30, 2020 |
| 8-K | Report | 8-K | Aug 13, 2020 | Aug 13, 2020 |
| 8-K | Report | 8-K | Jul 13, 2020 | Jul 13, 2020 |
| 8-K | Report | 8-K | Jun 30, 2020 | Jun 29, 2020 |
| 8-K | Report | 8-K | Jun 17, 2020 | Jun 11, 2020 |
| 10-Q | Report | Data | 10-Q | May 7, 2020 | Mar 31, 2020 |
| 8-K | Report | 8-K | May 7, 2020 | May 7, 2020 |
| SC 13D/A | Report | NEW ENTERPRISE ASSOCIATES 16, L.P. -- SCHEDULE 13DA1 | Apr 16, 2020 | |
| 10-K | Report | Data | 10-K | Mar 16, 2020 | Dec 31, 2019 |
| 8-K | Report | 8-K | Mar 16, 2020 | Mar 16, 2020 |
| 8-K | Report | 8-K | Feb 18, 2020 | Feb 13, 2020 |
| SC 13G | Report | ACQUISITION OF BENEFICIAL OWNERSHIP | Feb 13, 2020 | |
| SC 13G | Report | SC 13G | Jan 31, 2020 | |
| 8-K | Report | 8-K | Jan 6, 2020 | Dec 31, 2019 |
| 10-Q | Report | Data | 10-Q | Nov 14, 2019 | Sep 30, 2019 |
| 8-K | Report | 8-K | Nov 14, 2019 | Nov 14, 2019 |
| 8-K | Report | 8-K | Sep 24, 2019 | Sep 18, 2019 |
| 10-Q | Report | Data | 10-Q | Aug 12, 2019 | Jun 30, 2019 |
| 8-K | Report | 8-K | Aug 12, 2019 | Aug 12, 2019 |
| 8-K | Report | 8-K | Jul 2, 2019 | Jun 28, 2019 |
| 10-Q | Report | Data | 10-Q | Jun 14, 2019 | Mar 31, 2019 |
| 8-K | Report | 8-K | Jun 14, 2019 | Jun 13, 2019 |
| SC 13D | Report | NEW ENTERPRISE ASSOCIATES 16, L.P. - TREVI THERAPEUTICS, INC. 13D | May 20, 2019 | |
| SC 13D | Report | SC 13D | May 20, 2019 | |
| 8-K | Report | 8-K | May 9, 2019 | May 9, 2019 |